Systolic Heart failure treatment with the IF inhibitor ivabradine Trial - SHIFT

Description:

The goal of the trial was to evaluate the heart rate reducing agent ivabradine compared with placebo among patients with chronic heart failure. Ivabradine inhibits the If current in the sinoatrial node.